Tilray Brands Shares Surge Nearly 200% in Six Months Amid Regulatory Changes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2h ago
0mins
Source: Fool
- Stock Rebound: Tilray Brands' shares have surged nearly 200% over the past six months, reflecting market optimism for future growth despite the overall dismal performance of the cannabis sector.
- Regulatory Change: President Trump signed an executive order to reclassify marijuana as a Schedule 3 substance, which will facilitate easier access to research and banking services, potentially opening up growth opportunities for the industry.
- Market Potential: Although Tilray currently does not sell marijuana products in the U.S., its successful experience in the Canadian market could pave the way for future entry into the U.S. market, especially in the context of cannabis legalization.
- Competitive Challenges: Despite the positive regulatory changes, Tilray faces fierce competition from established cannabis companies in the U.S., which could lead to market share battles and oversupply issues, impacting its profitability.
TLRY
$10.53+Infinity%1D
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is 4.45 USD with a low forecast of 0.85 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
0 Hold
1 Sell
Moderate Buy
Current: 10.420
Low
0.85
Averages
4.45
High
10.00
Current: 10.420
Low
0.85
Averages
4.45
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
